Abstract | IMPORTANCE OF THE FIELD: AREAS COVERED IN THIS REVIEW: The pathophysiology of urinary dysfunction in MS and the efficacy and side effects of anticholinergics is assessed. The review analyzed randomized controlled trials and observational studies using anticholinergics involving persons with a confirmed diagnosis of MS having urinary symptoms. Finally a pragmatic approach to managing urinary symptoms in MS is discussed. WHAT THE READER WILL GAIN: The published data provide limited evidence for the efficacy of anticholinergics in MS. The complexity of treating urinary symptoms in the context of other therapies and the changing neurological background seen in MS is comprehensively analyzed. TAKE HOME MESSAGE:
|
Authors | Richard Nicholas, Carolyn Young, Tim Friede |
Journal | Expert opinion on drug safety
(Expert Opin Drug Saf)
Vol. 9
Issue 6
Pg. 905-15
(Nov 2010)
ISSN: 1744-764X [Electronic] England |
PMID | 20569078
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Central Nervous System Diseases
(complications)
- Cholinergic Antagonists
(therapeutic use)
- Combined Modality Therapy
- Disease Progression
- Drug Delivery Systems
- Humans
- Multiple Sclerosis
(complications)
- Randomized Controlled Trials as Topic
- Urinary Bladder, Overactive
(complications, drug therapy, physiopathology)
- Urologic Diseases
(complications, drug therapy, physiopathology)
|